{'fraction_non_alphanumeric': 0.02346041055718475, 'fraction_numerical': 0.005865102639296188, 'mean_word_length': 6.041237113402062, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Effect of oral contraceptives on the thromboelastogram

Thromboelastography, a method for studying clot kinetics and firmness, was performed on 1,133 women. Analysis of thromboelastographic parameters associated with contraceptive drug use revealed no differences between never and post users. Current users had shorter clotting times (R, K) and firmer clots (larger Ma), though very few subjects demonstrated extreme thromboelastographic hypercoagulability. These changes were not related to a specific brand, component, or dose of the contraceptive dmg. Longitudinal study is needed to determine whether these minor alterations in the thromboelastogram have clinical significance.